No photo of Luca Richeldi

Luca Richeldi

20182020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luca Richeldi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), Jan 1 2020, (Accepted/In press) In : Clinical Microbiology and Infection.

Research output: Contribution to journal › Review article

Open Access

    • Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

    Severe Asthma Network Italy (SANI), May 2020, In : Respiratory Medicine. 166, 105947.

    Research output: Contribution to journal › Article

    • Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

    Richeldi, L., Fernández Pérez, E. R., Costabel, U., Albera, C., Lederer, D. J., Flaherty, K. R., Ettinger, N., Perez, R., Scholand, M. B., Goldin, J., Peony Yu, K-H., Neff, T., Porter, S., Zhong, M., Gorina, E., Kouchakji, E. & Raghu, G., Jan 2020, In : The Lancet Respiratory Medicine. 8, 1, p. 25-33 9 p.

    Research output: Contribution to journal › Article

    • Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients

    Bianco, A., Mari, P-V., Larici, A. R., Lucchini, M., Nociti, V., Losavio, F. A., De Fino, C., Cicchetti, G., Coraci, D., Richeldi, L. & Mirabella, M., Oct 15 2019, In : Multiple Sclerosis and Related Disorders. 37, p. 101450

    Research output: Contribution to journal › Article

    • Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis

    Hill, C., Li, J., Liu, D., Conforti, F., Brereton, C. J., Yao, L., Zhou, Y., Alzetani, A., Chee, S. J., Marshall, B. G., Fletcher, S. V., Hancock, D., Ottensmeier, C. H., Steele, A. J., Downward, J., Richeldi, L., Lu, X., Davies, D. E., Jones, M. G. & Wang, Y., Aug 7 2019, In : Cell death & disease. 10, 8, p. 591

    Research output: Contribution to journal › Article